Clinical and immunological features of common variable immunodeficiency in China

Chinese Medical Journal

Volumn 128, Issue 3, 2015, Pages 310-315

  Lin, Lian Jun ^a   Wang, Yu Chuan ^a   Liu, Xin Min ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Common variable immunodeficiency; Immunoglobulin; Infection; Intravenous immunoglobulin therapy; Lymphocyte subset

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANAPHYLACTOID PURPURA; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; BRONCHIECTASIS; CHILD; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIARRHEA; DYSPNEA; EDEMA; FAINTNESS; FEMALE; FEVER; FLOW CYTOMETRY; GASTROINTESTINAL INFECTION; HEARING IMPAIRMENT; HEPATOSPLENOMEGALY; HUMAN; IMMUNE DEFICIENCY; JUVENILE RHEUMATOID ARTHRITIS; LOBECTOMY; LYMPHOMA; MALE; MIDDLE AGED; MUSCLE HYPERTROPHY; MYOSITIS; PALLIATIVE THERAPY; PNEUMONIA; PRESCHOOL CHILD; RECURRENT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SINUSITIS; SPUTUM; ULTRASOUND; YOUNG ADULT; COMMON VARIABLE IMMUNODEFICIENCY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADOLESCENT; ADULT; AGED; BRONCHIECTASIS; CHILD; CHILD, PRESCHOOL; CHINA; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; YOUNG ADULT;

EID: 84922453804     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.150092     Document Type: Article

References (23)

1. Abolhassani H, Sagvand BT, Shokuhfar T, Mirminachi B, Rezaei N, Aghamohammadi A. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol 2013; 9:561-74.
2. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
3. Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008; 46:1547-54.
4. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112:277-86.
5. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116:7-15.
6. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Q J Med 1993; 86:31-42.
7. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109:1001-4.
8. Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 2006; 39:114-20.
9. Aghamohammadi A, Abolhassani H, Hirbod-Mobarakeh A, Ghassemi F, Shahinpour S, Behniafard N, et al. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis. Viral Immunol 2012; 25:161-5.
10. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77-85.
11. Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 2006; 203:393-400.
12. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 2002; 16:61-4.
13. Chua I, Quinti I, Grimbacher B. Lymphoma in common variable immunodeficiency: Interplay between immune dysregulation, infection and genetics. Curr Opin Hematol 2008; 15:368-74.
14. Abolhassani H, Aghamohammadi A, Imanzadeh A, Mohammadinejad P, Sadeghi B, Rezaei N. Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol 2012; 22:133-4.
15. Oraei M, Aghamohammadi A, Rezaei N, Bidad K, Gheflati Z, Amirkhani A, et al. Naive CD4+ T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol 2012; 22:160-7.
16. Rezaei N, Aghamohammadi A, Nourizadeh M, Kardar GA, Pourpak Z, Zare A, et al. Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol 2010; 20:244-51.
17. Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency – An update. Arthritis Res Ther 2012; 14:223.
18. Rizzi M, Neumann C, Fielding AK, Marks R, Goldacker S, Thaventhiran J, et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol 2011; 128:1371-1374.e2.
19. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006; 117:S525-53.
20. Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 1995; 345:365-9.
21. Gardulf A. Immunoglobulin treatment for primary antibody deficiencies: Advantages of the subcutaneous route. BioDrugs 2007; 21:105-16.
22. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308-16.
23. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119:1650-7.